Metabolic syndrome and fatal outcomes in the post-stroke event: a 5-year cohort study in Cameroon
| dc.contributor.author | Balti, Eric Vounsia | en_ZA |
| dc.contributor.author | Kengne, André Pascal | en_ZA |
| dc.contributor.author | Fokouo, Jean Valentin Fogha | en_ZA |
| dc.contributor.author | Nouthé, Brice Enid | en_ZA |
| dc.contributor.author | Sobngwi, Eugene | en_ZA |
| dc.date.accessioned | 2016-01-11T06:56:14Z | |
| dc.date.available | 2016-01-11T06:56:14Z | |
| dc.date.issued | 2013 | en_ZA |
| dc.description.abstract | Background and Purpose: Determinants of post-acute stroke outcomes in Africa have been less investigated. We assessed the association of metabolic syndrome (MetS) and insulin resistance with post-stroke mortality in patients with first-ever-in-lifetime stroke in the capital city of Cameroon (sub-Saharan Africa). METHODS: Patients with an acute first-stroke event (n = 57) were recruited between May and October 2006, and followed for 5 years for mortality outcome. MetS definition was based on the Joint Interim Statement 2009, insulin sensitivity/resistance assessed via glucose-to-insulin ratio, quantitative insulin sensitivity check index and homeostatic model assessment. RESULTS: Overall, 24 (42%) patients deceased during follow-up. The prevalence of MetS was higher in patients who died after 28 days, 1 year and 5 years from any cause or cardiovascular-related causes (all p≤ 0.040). MetS was associated with an increased overall mortality both after 1 year (39% vs. 9%) and 5 years of follow-up (55% vs. 26%, p = 0.022). Similarly, fatal events due to cardiovascular-related conditions were more frequent in the presence of MetS both 1 year (37% vs. 9%) and 5 years after the first-ever-in-lifetime stroke (43% vs. 13%, p = 0.017). Unlike biochemical measures of insulin sensitivity and resistance (non-significant), in age- and sex-adjusted Cox models, MetS was associated with hazard ratio (95% CI) of 2.63 (1.03-6.73) and 3.54 (1.00-12.56) respectively for all-cause and cardiovascular mortality 5 years after stroke onset. CONCLUSION: The Joint Interim Statement 2009 definition of MetS may aid the identification of a subgroup of black African stroke patients who may benefit from intensification of risk factor management. | en_ZA |
| dc.identifier.apacitation | Balti, E. V., Kengne, A. P., Fokouo, J. V. F., Nouthé, B. E., & Sobngwi, E. (2013). Metabolic syndrome and fatal outcomes in the post-stroke event: a 5-year cohort study in Cameroon. <i>PLoS One</i>, http://hdl.handle.net/11427/16310 | en_ZA |
| dc.identifier.chicagocitation | Balti, Eric Vounsia, André Pascal Kengne, Jean Valentin Fogha Fokouo, Brice Enid Nouthé, and Eugene Sobngwi "Metabolic syndrome and fatal outcomes in the post-stroke event: a 5-year cohort study in Cameroon." <i>PLoS One</i> (2013) http://hdl.handle.net/11427/16310 | en_ZA |
| dc.identifier.citation | Balti, E. V., Kengne, A. P., Fokouo, J. V., Nouthé, B. E., & Sobngwi, E. (2013). Metabolic syndrome and fatal outcomes in the post-stroke event: a 5-year cohort study in Cameroon. PloS one, 8(4), e60117. doi:10.1371/journal.pone.0060117 | en_ZA |
| dc.identifier.ris | TY - Journal Article AU - Balti, Eric Vounsia AU - Kengne, André Pascal AU - Fokouo, Jean Valentin Fogha AU - Nouthé, Brice Enid AU - Sobngwi, Eugene AB - Background and Purpose: Determinants of post-acute stroke outcomes in Africa have been less investigated. We assessed the association of metabolic syndrome (MetS) and insulin resistance with post-stroke mortality in patients with first-ever-in-lifetime stroke in the capital city of Cameroon (sub-Saharan Africa). METHODS: Patients with an acute first-stroke event (n = 57) were recruited between May and October 2006, and followed for 5 years for mortality outcome. MetS definition was based on the Joint Interim Statement 2009, insulin sensitivity/resistance assessed via glucose-to-insulin ratio, quantitative insulin sensitivity check index and homeostatic model assessment. RESULTS: Overall, 24 (42%) patients deceased during follow-up. The prevalence of MetS was higher in patients who died after 28 days, 1 year and 5 years from any cause or cardiovascular-related causes (all p≤ 0.040). MetS was associated with an increased overall mortality both after 1 year (39% vs. 9%) and 5 years of follow-up (55% vs. 26%, p = 0.022). Similarly, fatal events due to cardiovascular-related conditions were more frequent in the presence of MetS both 1 year (37% vs. 9%) and 5 years after the first-ever-in-lifetime stroke (43% vs. 13%, p = 0.017). Unlike biochemical measures of insulin sensitivity and resistance (non-significant), in age- and sex-adjusted Cox models, MetS was associated with hazard ratio (95% CI) of 2.63 (1.03-6.73) and 3.54 (1.00-12.56) respectively for all-cause and cardiovascular mortality 5 years after stroke onset. CONCLUSION: The Joint Interim Statement 2009 definition of MetS may aid the identification of a subgroup of black African stroke patients who may benefit from intensification of risk factor management. DA - 2013 DB - OpenUCT DO - 10.1371/journal.pone.0060117 DP - University of Cape Town J1 - PLoS One LK - https://open.uct.ac.za PB - University of Cape Town PY - 2013 T1 - Metabolic syndrome and fatal outcomes in the post-stroke event: a 5-year cohort study in Cameroon TI - Metabolic syndrome and fatal outcomes in the post-stroke event: a 5-year cohort study in Cameroon UR - http://hdl.handle.net/11427/16310 ER - | en_ZA |
| dc.identifier.uri | http://hdl.handle.net/11427/16310 | |
| dc.identifier.uri | http://dx.doi.org/10.1371/journal.pone.0060117 | |
| dc.identifier.vancouvercitation | Balti EV, Kengne AP, Fokouo JVF, Nouthé BE, Sobngwi E. Metabolic syndrome and fatal outcomes in the post-stroke event: a 5-year cohort study in Cameroon. PLoS One. 2013; http://hdl.handle.net/11427/16310. | en_ZA |
| dc.language.iso | eng | en_ZA |
| dc.publisher | Public Library of Science | en_ZA |
| dc.publisher.department | Department of Medicine | en_ZA |
| dc.publisher.faculty | Faculty of Health Sciences | en_ZA |
| dc.publisher.institution | University of Cape Town | |
| dc.rights | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | en_ZA |
| dc.rights.holder | © 2013 Balti et al | en_ZA |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0 | en_ZA |
| dc.source | PLoS One | en_ZA |
| dc.source.uri | http://journals.plos.org/plosone | en_ZA |
| dc.subject.other | Death rates | en_ZA |
| dc.subject.other | Ischemic stroke | en_ZA |
| dc.subject.other | Cholesterol | en_ZA |
| dc.subject.other | Insulin | en_ZA |
| dc.subject.other | Insulin resistance | en_ZA |
| dc.subject.other | Stroke | en_ZA |
| dc.subject.other | Metabolic disorders | en_ZA |
| dc.subject.other | Blood pressure | en_ZA |
| dc.title | Metabolic syndrome and fatal outcomes in the post-stroke event: a 5-year cohort study in Cameroon | en_ZA |
| dc.type | Journal Article | en_ZA |
| uct.type.filetype | Text | |
| uct.type.filetype | Image | |
| uct.type.publication | Research | en_ZA |
| uct.type.resource | Article | en_ZA |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Balti_Metabolic_Syndrome_Fatal_Outcomes_2013.pdf
- Size:
- 651.35 KB
- Format:
- Adobe Portable Document Format
- Description: